Swiss National Bank
SRRA

Swiss National Bank’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Swiss National Bank’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-788
Closed -$206K – 2611
2016
Q1 		$206K Buy
788
+145
+23% +$46.3K ﹤0.01% 2553
2015
Q4 		$387K Buy
+643
New +$435K ﹤0.01% 2389

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

Swiss National Bank's SRRA Position: Q2 2016 in Review

Swiss National Bank sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2016, closing a stake of 788 shares — an estimated $206K sold.

Swiss National Bank first reported a position in SRRA in Q4 2015 and held it in 2 quarters. The position peaked at $387K in Q4 2015. 44 funds tracked by Wall St. Rank hold SRRA as of Q2 2016.

  • Swiss National Bank reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Swiss National Bank sold 788 Sierra Oncology, Inc. Common Stock shares in Q2 2016, an estimated $206K.
  • Swiss National Bank first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2015 and held it in 2 quarters.
  • Swiss National Bank's Sierra Oncology, Inc. Common Stock position peaked at $387K in Q4 2015.
  • 44 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2016.

Based on Swiss National Bank's 13F filing for Q2 2016, filed 3 Aug 2016.